Anzeige
Mehr »
Login
Dienstag, 16.04.2024 Börsentäglich über 12.000 News von 689 internationalen Medien
Biotech-Perle kurz vor entscheidender Meilenstein-Meldung!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 855526 | ISIN: JP3160400002 | Ticker-Symbol: EII
Tradegate
16.04.24
09:36 Uhr
36,970 Euro
+0,690
+1,90 %
Branche
Pharma
Aktienmarkt
NIKKEI-225
1-Jahres-Chart
EISAI CO LTD Chart 1 Jahr
5-Tage-Chart
EISAI CO LTD 5-Tage-Chart
RealtimeGeldBriefZeit
36,62036,85012:22
36,52036,90012:22

Aktuelle News zur EISAI Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
FrEisai on your hi-fi: Leqembi maker supports creation of Alzheimer's podcast miniseries314
03.04.French Sales Subsidiary Eisai S.A.S. to Divest Rights for Loxapac And Parkinane LP to CNX Therapeutics266TOKYO, Apr 3, 2024 - (JCN Newswire) - Eisai Co., Ltd. announced today that its French sales subsidiary Eisai S.A.S. entered into an agreement to transfer the rights in France, the French Overseas Territories...
► Artikel lesen
02.04.Eisai to divest rights for two therapies to Kaken3
01.04.Eisai and Biogen move to bring IV maintenance dosing for Leqembi to the US12
01.04.Eisai, Biogen's injectable Leqembi delayed as FDA asks for more data7
01.04.Eisai submits sBLA for monthly maintenance dose of Alzheimer's drug Leqembi3
01.04.Eisai Completes Submission of LEQEMBI (lecanemab-irmb) Supplemental Biologics License Application for IV Maintenance Dosing for the Treatment of Early Alzheimer's Disease to the U.S. FDA527TOKYO and CAMBRIDGE, Mass., Apr 1, 2024 - (JCN Newswire) - Eisai Co., Ltd. and Biogen Inc. announced today that Eisai submitted to the U.S. Food andDrug Administration (FDA) a Supplemental Biologics...
► Artikel lesen
01.04.Eisai Submits Leqembi SBLA For IV Maintenance Dosing In Early Alzheimer's Disease572WESTON (dpa-AFX) - Eisai submitted to the U.S. Food and Drug Administration a Supplemental Biologics License Application or sBLA for monthly lecanemab-irmb (U.S. brand name: Leqembi) intravenous...
► Artikel lesen
29.03.Eisai to Divest Rights for Merislon and Myonal in Japan to Kaken Pharmaceutical268TOKYO, Mar 29, 2024 - (JCN Newswire) - Eisai Co., Ltd. announced today that it has entered into an agreement to divest its rights for vertigo and equilibrium disturbance treatment Merislon (generic...
► Artikel lesen
29.03.Eisai's Brain Health Self-Check Tool "NouKNOW" is Certified as "ME-BYO BRAND" by Kanagawa Prefecture224TOKYO, Mar 29, 2024 - (JCN Newswire) - Eisai Co., Ltd. announced today that "NouKNOW", Eisai's self-check tool for brain health, was certified as a "ME-BYO BRAND" by Kanagawa prefecture.About "ME-BYO...
► Artikel lesen
29.03.Eisai: Discovery Research on Dual Orexin Receptor Antagonist Lemborexant Honored with PSJ Award for Drug Research and Development 2024298TOKYO, Mar 29, 2024 - (JCN Newswire) - Eisai Co., Ltd. announced today that drug discovery research conducted on lemborexant (brand name: Dayvigo), the dual orexin receptor antagonist discovered by...
► Artikel lesen
28.03.Dividendenbekanntmachungen (28.03.2024)11.927 Unternehmen  ISIN-Code  Dividende (Währung)  Dividende (EUR)  ACOM CO LTD  JP3108600002  6 JPY  0,0366 EUR  ADVANEX INC  JP3213400009  20 JPY  0,1222 EUR  AICA KOGYO CO LTD  JP3100800006  59 JPY  0...
► Artikel lesen
26.03.CHMP to Delay Nod on Biogen (BIIB), Eisai's Alzheimer's Drug18
25.03.Eisai and Biogen facing delay to Leqembi in Europe15
22.03.European Medicines Agency Delays Approval Decision For Biogen-Eisai Partnered Alzheimer's Drug Lecanemab7
22.03.EU delays decision on Eisai-Biogen Alzheimer's drug16
22.03.EU drug regulator does not refer to Eisai-Biogen Alzheimer's drug in meeting notes11
21.03.Eisai backs Leqembi's Japan rollout with insurance policy1
21.03.Lifenet and Eisai Co-Develop Dementia Insurance "be"399Supporting early detection and treatment of dementia and mild cognitive impairment (MCI) TOKYO, Mar 21, 2024 - (JCN Newswire) - LIFENET INSURANCE COMPANY and Eisai Co., Ltd. announced today that they...
► Artikel lesen
21.03.Eisai Selected as a Nadeshiko Brand 2024 as a Listed Company Excelling in Promotion of Women in the Workplace185TOKYO, Mar 21, 2024 - (JCN Newswire) - Eisai Co., Ltd. announced today that it has been selected for the first time by the Ministry of Economy, Trade and Industry (METI) and the Tokyo Stock Exchange...
► Artikel lesen
Seite:  Weiter >>
119 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1